The Evolving Landscape of Pulmonary Vascular Disease: Current Advances and Future Directions in Pulmonary Hypertension and Pulmonary Embolism. [PDF]
Cacia MA, Imbalzano E, Vatrano M.
europepmc +1 more source
From signal to significance: characterizing anthracycline-related hypercoagulable adverse events via pharmacovigilance, animal models, and clinical observation. [PDF]
Huang W, Shen J, Zhang J.
europepmc +1 more source
Inhaled pulmonary vasodilators in pulmonary hypertension: Perioperative use and clinical considerations. [PDF]
Klingbeil R +4 more
europepmc +1 more source
Correction: Xue et al. Untargeted Sweat Metabolomics and Targeted Plasma Amino Acid Profiling Reveal Dynamic Metabolic Remodeling During Conditioning in Yili Horses. <i>Biology</i> 2026, <i>15</i>, 1033. [PDF]
Xue Y +8 more
europepmc +1 more source
The Role of Platelets in Pulmonary Hypertension: From Activation to Pulmonary Vascular Remodeling-A Review Article. [PDF]
Wszelaki P +5 more
europepmc +1 more source
An Early Single-Center Case Series Experience With a Recently Introduced Formulation of Inhaled Treprostinil (Yutrepia). [PDF]
Moore CR +4 more
europepmc +1 more source
A Paradigm Shift of H<sub>2</sub>S Donors in Pulmonary Arterial Hypertension Toward Precision Delivery, Endogenous Activation, and Systemic Sensitization. [PDF]
Gao S, Chen X, Zhang C, Shen M, Han J.
europepmc +1 more source
Understanding pressure excursions in extracorporeal technologies: The role of shear stress and hematologic predisposition. [PDF]
El Dsouki Y +3 more
europepmc +1 more source
Transitioning From Oral to Intravenous Treprostinil in Pulmonary Arterial Hypertension: A Case Report. [PDF]
Cummings AM +3 more
europepmc +1 more source
Methamphetamine-Associated Pulmonary Arterial Hypertension in a Japanese Pulmonary Hypertension Referral Center. [PDF]
Fujisaki S +5 more
europepmc +1 more source

